MicroRNA ‐1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non‐small‐cell lung cancer
ConclusionsOur results indicate that miR ‐1258 can suppress NSCLC progression by targeting the GRB2/Ras/Erk pathway, which may lead to different insights into potential biomarkers and novel therapeutic strategies for NSCLC patients.
Source: Cell Proliferation - Category: Cytology Authors: Wei Jiang,
Ke Wei,
Chunfeng Pan,
Hong Li,
Jing Cao,
Xu Han,
Yu Tang,
Shichao Zhu,
Weiwei Yuan,
Yaozhou He,
Yang Xia,
Liang Chen,
Yijiang Chen Tags: ORIGINAL ARTICLE Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cytology | Gastric (Stomach) Cancer | Gastroenterology | Lung Cancer | Non-Small Cell Lung Cancer